Evicenter
P&T meetings

Deramiocel (CAP-1002)

Duchenne muscular dystrophy

Launch
Not announced
Last updated
92 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Duchenne muscular dystrophy

Economic burden and healthcare resource utilization

5 evidence topics · 6 sources

Health-state utilities, costs, and healthcare resource use in DMD

“There was heterogeneity between studies and a lack of long-term data in both SLRs.” (opens the source at this quote in a new tab)

Economic burden systematic review

“the mean per-patient annual direct medical cost of illness (in 2025 international US dollars) was estimated at between $2620 and $209,980” (opens the source at this quote in a new tab)

United States medical costs: Medicaid and commercial insurance

“(in 2018 USD)” (opens the source at this quote in a new tab)

“median (IQR) monthly costs were similar at $1,735 ($367-$5,281) for the Medicaid DMD cohort vs $1,883 ($657-$6,796) for the commercial DMD cohort.” (opens the source at this quote in a new tab)

Multinational cost-of-illness study

“Mean per-patient annual direct cost of illness was estimated at between $23,920 and $54,270 (2012 international dollars)” (opens the source at this quote in a new tab)

United States healthcare costs: DMD versus matched non-MD controls

“mean unadjusted total healthcare costs (US$103,826.05 ± 309,335.71) per patient per year compared with patients with non-MD (US$3225.30 ± 13,865.14; p < 0.0001)” (opens the source at this quote in a new tab)